Usana Health Sciences (FRA:USJ) EV-to-EBIT : 5.93 (As of Jun. 04, 2024)

View and export this data going back to . Start your Free Trial

What is Usana Health Sciences EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Usana Health Sciences's Enterprise Value is €555.0 Mil. Usana Health Sciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €93.6 Mil. Therefore, Usana Health Sciences's EV-to-EBIT for today is 5.93.

The historical rank and industry rank for Usana Health Sciences's EV-to-EBIT or its related term are showing as below:

FRA:USJ' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.05 Med: 9.26 Max: 18.27
Current: 5.93

During the past 13 years, the highest EV-to-EBIT of Usana Health Sciences was 18.27. The lowest was 5.05. And the median was 9.26.

FRA:USJ's EV-to-EBIT is ranked better than
85.69% of 1488 companies
in the Consumer Packaged Goods industry
Industry Median: 13.795 vs FRA:USJ: 5.93

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Usana Health Sciences's Enterprise Value for the quarter that ended in Mar. 2024 was €544.8 Mil. Usana Health Sciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €93.6 Mil. Usana Health Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 17.18%.

Usana Health Sciences EV-to-EBIT Historical Data

The historical data trend for Usana Health Sciences's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Usana Health Sciences EV-to-EBIT Chart

Usana Health Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

9.79

7.39

10.13

6.80

6.84

Usana Health Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															8.83	9.03	8.24	6.84	5.89

Competitive Comparison of Usana Health Sciences's EV-to-EBIT

For the Packaged Foods subindustry, Usana Health Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Usana Health Sciences's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Usana Health Sciences's EV-to-EBIT falls into.

Usana Health Sciences EV-to-EBIT Calculation

Usana Health Sciences's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	554.965	/	93.588
	=	5.93

Usana Health Sciences's current Enterprise Value is €555.0 Mil.
Usana Health Sciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €93.6 Mil.

Usana Health Sciences (FRA:USJ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Usana Health Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	93.588	/	544.8318
	=	17.18 %

Usana Health Sciences's Enterprise Value for the quarter that ended in Mar. 2024 was €544.8 Mil.
Usana Health Sciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €93.6 Mil.

Usana Health Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Usana Health Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Usana Health Sciences (FRA:USJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Usana Health Sciences Inc (FRA:USJ) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

USNA:USA

Address

3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120

Website

http://www.usanahealthsciences.com

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.

Usana Health Sciences (FRA:USJ) Headlines

No Headlines